The reduction of increased platelet aggregation in essential hypertens
ion is one of the aims of modern antihypertensive therapy. Twenty-one
hospitalized patients with non-treated essential hypertension were exa
mined. The platelet function measurements were made before the therapy
and after 1 week of celiprolol administration (300 mg/day). Fifteen e
ssentially hypertensive patients were investigated before and after 1
week of placebo administration. Plasma beta-thromboglobulin was assaye
d, and the whole blood platelet aggregation (initial and total - induc
ed by adrenaline and ADP) was measured. A significant decrease in adre
naline-induced (from 19 to 13%, p < 0.02) and ADP-induced aggregation
(from 15 to 13%, p < 0.05) was observed after celiprolol administratio
n. This reduction of adrenaline-induced platelet aggregation may be ex
plained by the stimulation effect of celiprolol on platelet beta2-rece
ptors. Thus, some inhibitory effect of celiprolol on platelet aggregat
ion is one of the further advantages of this drug in the therapy of es
sential hypertension.